Six years experience of pediatric liver transplantation——13 cases reports

刘树立,李龙,侯文英,黄柳明,朱继业,冷希胜,王文雅,张军,周晓龙

DOI: https://doi.org/10.3760/cma.j.issn.0253-3006.2008.07.011

2008-01-01

Abstract:Objective To present our experience of pediatric liver transplantation(LT) in 13 children. Methods From November 2001 to July 2007, 13 patients with end-stage liver diseases were performed LT. Among them, 7 were biliary atresia, 3 were congenital hepatic fibrosis, 1 was Caroli's disease, 1 was Wilson's disease, and the other one was hepatohemoangioendotheliosarcoma. Patients" age ranged from 5 months to 12 years. Four of 13 children underwent parental living donor liver trans-plantation (LDLT), among whom 1 was right lobe transplantation and 3 were left lateral lobe trans-plantation. Seven recipients underwent reduced size LT, whose grafts were the left lobe of 4 cases and left lateral lobe of 3 cases. The other 2 children underwent split LT, and the grafts were segmental graft (segment Ⅱ) and right posterior segment graft. The liver was totally removed in 11 recipients, and the whole liver and retrohaptic inferior vena cave were removed in the other 2 recipients. Results Grafts" weight of recipients ranged from 261) g to 565 g(1.7%-3%BW). LDLT donors and all recipients had been followed up for up to 6 years after operation. All of the four I.DLT donors recovered soon after the operation without any complication. Three of the four LDLT recipients have survived till now without any complications, the other Ⅰ was died of acute necrotizing enterocolitis. One of the nine patients underwent cadaver LT was re-transplanted for chronic rejection on the 14th month after operation, 5 of them have survived till now. From January of 2001 to October of 2003, 6 LTs were performed, 5 recipients died, and 2 years survival rate was 33. 3%. From April of 2004 to April of 2007, 7 LTs were performed, only 1 recipient died, and 2 years survival rate was 57. 1%. Conclusions Liver transplantation is an effective treatment for the children with end-stage liver disease. The indication should be controlled strictly. Patient's condition, family finance and mental stress should also be taken into consideration. The mortality and complication will decrease significantly with surgeon's experience increase.